Incidence and Risk of Sorafenib-Induced Hypertension: A Systematic Review and Meta-Analysis
Author:
Affiliation:
1. Department of Urology; Qilu Hospital, Shandong University; Jinan China
2. Department of Urology; Qianfoshan Hospital, Shandong University; Jinan China
3. Department of Drug Monitoring Center; Qilu Hospital, Shandong University; Jinan China
Publisher
Wiley
Subject
Cardiology and Cardiovascular Medicine,Endocrinology, Diabetes and Metabolism,Internal Medicine
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/jch.12273/fullpdf
Reference78 articles.
1. BAY 43-9006 exhibits broad spectrum oral antitumor activity and targets the RAF/MEK/ERK pathway and receptor tyrosine kinases involved in tumor progression and angiogenesis;Wilhelm;Cancer Res,2004
2. Hepatocellular carcinoma: ESMO-ESDO Clinical Practice Guidelines for diagnosis, treatment and follow-up;Verslype;Ann Oncol,2012
3. Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up;Escudier;Ann Oncol,2012
4. Phase II trial of sorafenib in advanced thyroid cancer;Gupta-Abramson;J Clin Oncol,2008
5. A phase II trial of sorafenib in metastatic melanoma with tissue correlates;Ott;PLoS ONE,2010
Cited by 59 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Ocular and systemic vascular endothelial growth factor ligand inhibitor use and nephrotoxicity: an update;International Urology and Nephrology;2024-03-18
2. Understanding Sorafenib-Induced Cardiovascular Toxicity: Mechanisms and Treatment Implications;Drug Design, Development and Therapy;2024-03
3. Impact on clinical outcomes of renin-angiotensin system inhibitors against doxorubicin-related toxicity in patients with breast cancer and hypertension: A nationwide cohort study in South Korea;PLOS ONE;2023-11-20
4. The Effects of Drug Exposure and Single Nucleotide Polymorphisms on Aaptinib-Induced Severe Toxicities in Solid Tumors;Drug Metabolism and Disposition;2023-09-29
5. Safety and toxicity of cabozantinib monotherapy in patients with advanced renal cell carcinoma: a Russian multicenter observational study;Journal of Modern Oncology;2023-08-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3